Johnson & Johnson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. 

CEO
Joaquin Duato
CEOJoaquin Duato
Employees
140,800
Employees140,800
Headquarters
New Brunswick, New Jersey
HeadquartersNew Brunswick, New Jersey
Founded
1887
Founded1887
Employees
140,800
Employees140,800

JNJ Key Statistics

Market cap
667.20B
Market cap667.20B
Price-Earnings ratio
28.97
Price-Earnings ratio28.97
Dividend yield
2.10%
Dividend yield2.10%
Average volume
8.97M
Average volume8.97M
High today
$271.30
High today$271.30
Low today
$261.35
Low today$261.35
Open price
$262.90
Open price$262.90
Volume
9.65M
Volume9.65M
52 Week high
$271.30
52 Week high$271.30
52 Week low
$164.23
52 Week low$164.23

Stock Snapshot

With a market cap of 667.2B, Johnson & Johnson(JNJ) trades at $270.30. The stock has a price-to-earnings ratio of 28.97 and currently yields dividends of 2.10%.

As of 2026-07-28, Johnson & Johnson(JNJ) stock has fluctuated between $261.35 and $271.30. The current price stands at $270.30, placing the stock +3.4% above today's low and -0.4% off the high.

The Johnson & Johnson(JNJ)'s current trading volume is 9.65M, compared to an average daily volume of 8.97M.

In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $271.30 and a 52-week low of $164.23.

In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $271.30 and a 52-week low of $164.23.

JNJ News

TipRanks 25m
J&J Strikes $5.5B Talc Settlement after Years of Lawsuits; JNJ Stock Rises

Johnson & Johnson (JNJ) shares rose 1.52% in after-hours trading on Monday after the company announced a $5.5 billion settlement to resolve tens of thousands of...

Simply Wall St 4h
Johnson And Johnson Talc Settlement Puts Colgate And Kimberly Clark Stock In Focus

Legal shockwaves from Johnson & Johnson’s proposed $5.5b talc settlement are rippling through the baby care and personal health space, reshaping how investors t...

Johnson And Johnson Talc Settlement Puts Colgate And Kimberly Clark Stock In Focus
BBC 6h
Johnson & Johnson offers to pay $5.5bn to settle baby powder lawsuits - BBC

...

Johnson & Johnson offers to pay $5.5bn to settle baby powder lawsuits - BBC

Analyst ratings

73%

of 26 ratings
Buy
73.1%
Hold
23.1%
Sell
3.8%

More JNJ News

24/7 Wall St. 7h
Why Chasing a 9% Yield Could Cost You $200,000 in Retirement Income

Why Chasing a 9% Yield Could Cost You $200,000 in Retirement Income By Michael Williams Published Jul 27, 8:25PM EDT Quick Read Generating $60,000 in retireme...

Why Chasing a 9% Yield Could Cost You $200,000 in Retirement Income
Seeking Alpha 7h
Johnson & Johnson to pay up to $5.5B to settle talc lawsuits

Johnson & Johnson (JNJ) up 1.4% post-market Monday after saying it agreed to pay up to $5.5B to settle remaining lawsuits that alleged its talc products caused...

Johnson & Johnson to pay up to $5.5B to settle talc lawsuits
TipRanks 9h
J&J announces proposed resolution of ovarian talc litigation

Johnson & Johnson announced that it has reached an agreement for a comprehensive resolution of the remaining talc litigation with the plaintiff firms leading th...

TipRanks 9h
J&J to settle ovarian talc claims for $5.5B

18:34 EDT J&J to settle ovarian talc claims for $5.5B Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try...

TipRanks 15h
After industry event, Piper sees Intuitive Surgical as dominant player

After attending the Society of Robotic Surgery meeting, Piper Sandler sees “lots of greenfield ahead” for the soft tissue robotic category. While robot-assisted...

Nasdaq 16h
J&J's MedTech Performance Slows in Q2: Will Sales Improve in H2?

Johnson & Johnson's JNJ medical devices segment, known as MedTech, offers products in the orthopedics, surgery, cardiovascular and vision markets. The MedTech s...

J&J's MedTech Performance Slows in Q2: Will Sales Improve in H2?
24/7 Wall St. 16h
Forget Social Security: 5 Sleep-at-Night Dividend Stocks Retirees Are Using to Replace a Paycheck

Forget Social Security: 5 Sleep-at-Night Dividend Stocks Retirees Are Using to Replace a Paycheck By Joel South Published Jul 27, 11:40AM EDT Quick Read Realt...

Forget Social Security: 5 Sleep-at-Night Dividend Stocks Retirees Are Using to Replace a Paycheck

People also own

Based on the portfolios of people who own JNJ. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.